Auteurs

Chris Thornham

Associé

Read More

Laurence Lieberman

Associé

Read More

Colin McCall

Associé

Read More
Auteurs

Chris Thornham

Associé

Read More

Laurence Lieberman

Associé

Read More

Colin McCall

Associé

Read More

29 septembre 2019 |

Arbitration considerations for life science companies

In the second instalment of our life sciences disputes webinar series – we provided practical tips and advice, discussed key legislation and shared case studies on how life sciences organisations can mitigate and manage their litigation risk, including:

  • What subject-matter can be arbitrated and how arbitration may arise.
  • Typical advantages / disadvantages of arbitration versus litigation.
  • Industry–specific points for parties in the life sciences considering arbitration.
  • Arbitration proceedings rules, tribunal composition, location and choice of law.
  • Decisions, remedies, enforcement and challenges.


View the first webinar in our series: Managing cybersecurity risk from a life sciences perspective


Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Sciences de la vie et Santé

Termination, force majeure and frustration – international perspectives on the life sciences sector

17 avril 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus

Événements connexes